Package 16714-820-01

Brand: tenofovir disoproxil fumarate

Generic: tenofovir disoproxil fumarate
NDC Package

Package Facts

Identity

Package NDC 16714-820-01
Digits Only 1671482001
Product NDC 16714-820
Product ID 16714-820_eaeb1670-4e39-4541-8ff7-47057f3f5c36
Description

30 TABLET, FILM COATED in 1 BOTTLE (16714-820-01)

Marketing

Marketing Status
Marketed Since 2018-11-12
Brand tenofovir disoproxil fumarate
Generic tenofovir disoproxil fumarate
Sample Package No

Linked Drug Pages (1)

Tenofovir Disoproxil Fumarate ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "eaeb1670-4e39-4541-8ff7-47057f3f5c36", "openfda": {"upc": ["0316714820019"], "unii": ["OTT9J7900I"], "rxcui": ["349251"], "spl_set_id": ["eaeb1670-4e39-4541-8ff7-47057f3f5c36"], "manufacturer_name": ["NorthStar RxLLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (16714-820-01)", "package_ndc": "16714-820-01", "marketing_start_date": "20181112"}], "brand_name": "Tenofovir Disoproxil Fumarate", "product_id": "16714-820_eaeb1670-4e39-4541-8ff7-47057f3f5c36", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]"], "product_ndc": "16714-820", "generic_name": "Tenofovir Disoproxil Fumarate", "labeler_name": "NorthStar RxLLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tenofovir Disoproxil Fumarate", "active_ingredients": [{"name": "TENOFOVIR DISOPROXIL FUMARATE", "strength": "300 mg/1"}], "application_number": "ANDA090636", "marketing_category": "ANDA", "marketing_start_date": "20181112", "listing_expiration_date": "20261231"}